Lab-grown red cells from immortalized erythroid precursor cell lines as an alternative source of red cells with infrequent or rare phenotypes

Principal Investigator

Laia Miquel

Duration

2023 – 2026

Funded by

BST

Objective

To provide an alternative source of red blood cells, not dependent on voluntary blood donation, by developing a novel bioprocess to increase red blood cell production from imERYPC lines with selected blood group phenotypes